Full info forMTPC
| Application ID | 1-988-84412 |
| Status | IE Pass |
| Prioritization Number | 593 |
| TLD (#13) | MTPC |
| IDN Translation (#14b) | -- |
| Applicant (#1) | Mitsubishi Tanabe Pharma Corporation |
| Website (#5) | http://www.mt-pharma.co.jp/e |
| Application Type | |
| Type | Standard |
| Contested | no |
| Contested Numbers | 1 |
| GAC Early Warning | no |
| Cultural, Linguistic or Religious | no |
| dotBrand | yes |
| Trademark Class A | class 5 (pharma, dietetic food) |
| Trademark Class B | |
| Trademark Class C | |
| Industry Keyword | healthcare |
| Remark | Mitsubishi Tanabe Pharma Corporation is a global research-driven pharmaceutical company, which engages in research and development, as well as manufacturing and sales, of pharmaceutical product. |
| Availability Data | |
| Sunrise Period: | fromunknown tounknown |
| Landrush Period: | fromunknown tounknown |
| GoLive: | unknown |
| Registration Policy | |
| Restricted | yes |
| Restrictions | dotbrand |
| Backend Provider | GMO Registry |
| Registry Website | |
| Keyword | |
| Keyword | no |
| English Meaning | -- |
| Appeal Ranking | 0 |
| Appeal Remark | Reserved for company and affiliate use only. |
| English | not applicable |
| Spanish | not applicable |
| Portuguese | not applicable |
| French | not applicable |
| Italian | not applicable |
| German | not applicable |
| Dutch | not applicable |
| Swedish | not applicable |
| Danish | not applicable |
| Mandarin | not applicable |
| Russian | not applicable |
| Location | |
| Region | Asia Pacific |
| Country | Japan |
| Community (#19) | -- |
| Geographic (#21a) | -- |
| Geographic Category | -- |
| IDN | |
| IDN (#14) | No |
| A-label (#14a) | -- |
| Translation (#14b) | -- |
| Script Code (#14d) | -- |
| Allows ASCII | yes |
| Applicant | |
| Applicant (#1) | Mitsubishi Tanabe Pharma Corporation |
| Website (#5) | http://www.mt-pharma.co.jp/e |
| Applicant Address (#2) | 2-6-18, Kitahama, Chuo-ku Osaka 541-8505 Japan [JP] |
| Applicant Phone (#3) | +81 6 6205 5085 |
| Applicant Fax (#4) | +81 6 6205 5262 |
| Legal Form (#8) | Corporation |
| Exchange Symbol (#9a) | Tokyo_Stock_Exchange |
| Parent Company (#9b) | Mitsubishi Chemical Holdings Corporation |
| Joint Venture Partners (#9c) | |
| Primary Contact | |
| Name (#6) | Mr. Yoshihisa Saso |
| Title (#6) | General Manager |
| e-mail (#6) | mtpc@gmoregistry.com |
| Secondary Contact | |
| Name (#7) | Mr. Hirokatsu Ohigashi |
| Title (#7) | Executive Director |
| e-mail (#7) | newgtld@gmoregistry.com |
| Mission / Purpose (#18a) | |
| Mitsubishi Tanabe Pharma Corporation is a global research-driven pharmaceutical company, which engages in research and development, as well as manufacturing and sales, of pharmaceutical product. The company was established in October 2007 through the merger of Tanabe Seiyaku Co., Ltd., founded in 1678, and Mitsubishi Pharma Corporation. Sine that time, the company has contributed to the health of people through the provision of distinctive pharmaceuticals, including drugs for inflammatory and autoimmune diseases, cerebral diseases, and metabolic and cardiorascular diseases as well as psychiatric and neurological drugs, narcotics, plasma fractionation products, and vaccines. Based on its philosophy ʺWe contribute to the healthier lives of people around the world through the creation of pharmaceuticalsʺ, Mitsubishi Tanabe Pharma strives to be a company that is trusted by communities. .mtpc, which stands for Mitsubishi Tanabe Pharma Corporation, is a domain for Mitsubishi Tanabe Pharma and its stakeholders. The primary purpose of .mtpc is to consolidate Mitsubishi Tanabe Pharma-related domain names registered under various TLDs into an official .mtpc extension. In addition, Mitsubishi Tanabe Pharma aims to achieve the following goals with .mtpc: 1. Alleviating user confusion and improving convenience for Internet users Mitsubishi Tanabe Pharma Corporation is a global company selling a multitude of products including (1) Manufacture and sale of pharmaceuticals, centered on ethical pharmaceuticals (2) Manufacture and sale of fine chemicals and active pharmaceutical ingredients ⁄ intermediates. The company has registered many domain names under various gTLDs and ccTLDs not only for actual use but also as a trademark protection measure. Despite these efforts, there exist many domain name registrations and websites that infringe Mitsubishi Tanabe Pharma Corporation’s trademarks. As a result, Internet users often have difficulty differentiating bona fide websites from fraudulent ones. Positioning .mtpc as the official domain for the company, and unifying the company⁄brand’s web presence under .mtpc, would provide easy access and interaction, which the company believes would reduce confusion and improve user experience. 2. Marketing ⁄ Branding Since .mtpc is a brand new TLD that directly represents the company⁄brand name, Mitsubishi Tanabe Pharma Corporation expects it to be a highly effective marketing and branding tool. The company believes that .mtpc will not only reinforce Mitsubishi Tanabe Pharma Corporation’s brand on the Internet, but also attract people to visit the website because .mtpc domain names make it easier for Internet users to access to the information related to the company. 3. Simplifying domain name management The third purpose for applying for .mtpc is to simplify the management of domain names the company has registered. As stated earlier, Mitsubishi Tanabe Pharma Corporation has many domain names under the various TLDs, posing a challenge in dealing with different registration and operation rules, log-in systems, etc. .mtpc would make it possible to manage domain names under the .mtpc rules and systems umbrella and would replace various Mitsubishi Tanabe Pharma Corporation related domain names with .mtpc domain names. As a consequence, it will be safer and easier for the .mtpc stakeholders to manage their domain names. |
|
If you wish to download the application information pertaining to this new gTLD, please select your download preference below: 1) A PDF compilation of the information provided by eBrand Services will be generated for you.; 2) The public portion of the application made available by ICANN will be generated.
Be informed about the status of applicationMTPC
Do you want to be kept up to date with the application status for a domain under a new gTLD?
We understand that the roll out of the new gTLD’s is a long process and you may be undecided on the specific domain you wish to pursue. Nonetheless, if you would like to be informed about the progress of a particular new gTLD, and all essential elements (policies, pricing, launch schedules, and registration deadlines), request a follow up and join our watchlist. Alternatively, let us review your business/situation and supply you with a customized solution fitting your individual needs.
File an objection for applicationMTPC
eBrand Services has designed a series of defensive approaches to ensure that rightholders can object applications of new gTLD that affect their interests asserting prior rights over certain string or Trademark. Contact us to know more:
Express your interest for a domain name under the extensionMTPC
An Expression of Interest allows you to submit a non-binding interest in registering the specific domains most relevant to you. By doing so, we can provide you with up-to-date information about launch schedules, pricing, policies, and ensure you avoid missing registration deadlines. Prior to the release of your domain name under a new gTLD, we will let you know and we can assist you in turning your Expression of Interest into a binding registration order, or cancel your Expression of Interest. Whilst we will endeavor to secure your desired domain for you, please note that we cannot guarantee a successful registration. It is important to acknowledge that multiple registration phases will take place. For more information, please refer our FAQ’s. All Expression of Interest’s are free of charge and legally non-binding.
Additionally, let us review your business/situation and supply you with a customized solution fitting your individual needs.
Contact us to know more: